D-0123-2018 Class I Terminated
FDA drug recall D-0123-2018 was initiated by Pfizer Inc. on August 30, 2017 and is designated Class I. Reason for recall: Presence of Particulate Matter: glass particulate found in vial The recall status is terminated (terminated November 8, 2018). Affected quantity: 102,500 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- December 27, 2017
- Initiation Date
- August 30, 2017
- Termination Date
- November 8, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 102,500 vials
Product Description
Vancomycin Hydrochloride for Injection, USP. 750 mg. Sterile Powder. Rx Only. Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-6531-02
Reason for Recall
Presence of Particulate Matter: glass particulate found in vial
Distribution Pattern
Nationwide USA and Puerto Rico
Code Information
Lot: 632153A; Exp. 03/18